Impact of Synergistic polymorphisms in adrenergic receptor-related genes and cardiovascular events in patients with dilated cardiomyopathy

Circulation Journal

Volumn 76, Issue 8, 2012, Pages 2003-2008

  Ogimoto, Akiyoshi ^a   Okayama, Hideki ^a   Nagai, Takayuki ^a   Suzuki, Jun ^a   Inoue, Katsuji ^a   Nishimura, Kazuhisa ^a   Shigematsu, Yuji ^a   Tabara, Yasuharu ^a   Miki, Tetsuro ^a   Higaki, Jitsuo ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenergic receptor; Dilated cardiomyopathy; Polymorphism; Prognosis

Indexed keywords

ARGININE; BRAIN NATRIURETIC PEPTIDE; GLYCINE; SERINE;

ADRENERGIC RECEPTOR BETA 1 GENE; ADULT; AGED; ALLELE; ARTICLE; CEREBROVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISEASE CARRIER; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HEART ARRHYTHMIA; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; NORADRENALIN RELEASE; NOREPINEPHRINE TRANSPORTER GENE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CARDIOMYOPATHY, DILATED; DISEASE-FREE SURVIVAL; FEMALE; GENETIC LOCI; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-1; SURVIVAL RATE;

EID: 84864390288     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1014     Document Type: Article

References (24)

1. Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000; 343: 1688-1696.
2. Morimoto S. Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res 2008; 77: 659-666.
3. Sigusch HH, Lehmann MH, Schnittler U, Reinhardt D, Figulla HR. Tumour necrosis factor-alpha expression in idiopathic dilated cardiomyopathy: Correlation to myocardial inflammatory activity. Cytokine 2000; 12: 1261-1266.
4. Ogimoto A, Okayama H, Nagai T, Ohtsuka T, Suzuki J, Inoue K, et al. Association of monocyte chemoattractant protein 1 gene polymorphism with susceptibility to nonfamilial idiopathic dilated cardiomyopathy. J Cardiol 2009; 54: 66-70.
5. Caforio AL, Keeling PJ, Zachara E, Mestroni L, Camerini F, Mann JM, et al. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 1994; 344: 773-777.
6. Kimura A. Contribution of genetic factors to the pathogenesis of dilated cardiomyopathy: The cause of dilated cardiomyopathy: Genetic or acquired? (Genetic-side) Circ J 2011; 75: 1756-1765.
7. Yoshikawa T. Contribution of acquired factors to the pathogenesis of dilated cardiomyopathy: The cause of dilated cardiomyopathy: Genetic or acquired? (Acquired-side) Circ J 2011; 75: 1766-1773.
8. Forleo C, Resta N, Sorrentino S, Guida P, Manghisi A, De Luca V, et al. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy. Am J Med 2004; 117: 451-458.
9. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995; 26: 1257-1263.
10. Iwai C, Akita H, Shiga N, Takai E, Miyamoto Y, Shimizu M, et al. Suppressive effect of the Gly389 allele of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy. Circ J 2002; 66: 723-728.
11. Azuma J, Nonen S. Chronic heart failure: Beta-blockers and pharmacogenetics. Eur J Clin Pharmacol 2009; 65: 3-17.
12. Muthumala A, Drenos F, Elliott PM, Humphries SE. Role of beta adrenergic receptor polymorphisms in heart failure: Systematic review and meta-analysis. Eur J Heart Fail 2008; 10: 3-13.
13. Biolo A, Clausell N, Santos KG, Salvaro R, Ashton-Prolla P, Borges A, et al. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy. Am J Cardiol 2008; 102: 726-732.
14. Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB. Synergistic polymorphisms of beta1and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 2002; 347: 1135-1142.
15. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, et al. Orthostatic intolerance and tachycardia associated with norepinephrinetransporter deficiency. N Engl J Med 2000; 342: 541-549.
16. Nonen S, Okamoto H, Fujio Y, Takemoto Y, Yoshiyama M, Hamaguchi T, et al. Polymorphisms of norepinephrine transporter and adrenergic receptor alpha1D are associated with the response to beta-blockers in dilated cardiomyopathy. Pharmacogenomics J 2008; 8: 78-84.
17. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/ International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93: 841-842.
18. Ogimoto A, Shigematsu Y, Nakura J, Hara Y, Ohtsuka T, Kohara K, et al. Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) in patients with coexistent hypertrophic cardiomyopathy and coronary spastic angina. J Mol Med 2005; 83: 619-625.
19. Brodde OE. Beta-1 and beta-2 adrenoceptor polymorphisms: Functional importance, impact on cardiovascular diseases and drug responses. Pharmacol Ther 2008; 117: 1-29.
20. Kaye DM, Smirk B, Finch S, Williams C, Esler MD. Interaction between cardiac sympathetic drive and heart rate in heart failure: Modulation by adrenergic receptor genotype. J Am Coll Cardiol 2004; 44: 2008-2015.
21. Sehnert AJ, Daniels SE, Elashoff M, Wingrove JA, Burrow CR, Horne B, et al. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol. J Am Coll Cardiol 2008; 52: 644-651.
22. Kawahara C, Tsutamoto T, Nishiyama K, Yamaji M, Sakai H, Fujii M, et al. Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy. Circ J 2011; 75: 656-661.
23. McNamara DM, Holubkov R, Postava L, Ramani R, Janosko K, Mathier M, et al. Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure. Circulation 2003; 107: 1598-1602.
24. McNamara DM, Holubkov R, Janosko K, Palmer A, Wang JJ, MacGowan GA, et al. Pharmacogenetic interactions between betablocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. Circulation 2001; 103: 1644-1648.